>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

Action Alert: Medicare payments to be cut by 21 percent next week – Ask your Senators to repeal the SGR

Monday, February 22, 2010

Call your Senators today - even if you have already called!   Tell them they must act now to permanently repeal the flawed Sustainable Growth Rate formula (SGR) before a 21 percent pay cut goes into effect next Monday – March 1.

As you will recall, prior to the December Congressional recess, Congress passed, and the President signed into law, legislation temporarily halting a massive 21 percent Medicare payment cut.  The legislation is set to expire February 28.  Without the enactment of new SGR reform legislation prior to the end of February, anesthesiologists and all other physicians will experience a 21 percent payment cut beginning March 1, with additional cuts projected in future years.

ASA has been urging House and Senate lawmakers to move forward with meaningful legislation to eliminate the flawed SGR formula.  These lawmakers have been meeting regarding the issue but, to date, no formal proposal has been forthcoming.  

ASA is now joining with our colleagues in the surgical and larger medical community to urge Congress to act immediately.  Legislation must be enacted this week to prevent the massive cut from taking effect.

Please call your Senators and urge them to adopt meaningful SGR reform, similar to the House passed bill, the “Medicare Physician Payment Reform Act,” H.R. 3961, before the cuts take effect.  Congress must work to end these egregious payment cuts once and for all.

« Back to Washington Alerts